- Home
- CLLS vs NEN Comparison
CLLS vs NEN Comparison
Compare CLLS & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- NEN
- Stock Information
- Founded
- CLLS 1999
- NEN 1977
- Country
- CLLS France
- NEN United States
- Employees
- CLLS N/A
- NEN N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- NEN Building operators
- Sector
- CLLS Health Care
- NEN Real Estate
- Exchange
- CLLS Nasdaq
- NEN Nasdaq
- Market Cap
- CLLS 240.2M
- NEN 248.2M
- IPO Year
- CLLS 2007
- NEN N/A
- Fundamental
- Price
- CLLS $1.97
- NEN $81.00
- Analyst Decision
- CLLS Buy
- NEN
- Analyst Count
- CLLS 2
- NEN 0
- Target Price
- CLLS $8.00
- NEN N/A
- AVG Volume (30 Days)
- CLLS 22.5K
- NEN 335.0
- Earning Date
- CLLS 11-04-2024
- NEN 01-01-0001
- Dividend Yield
- CLLS N/A
- NEN 1.98%
- EPS Growth
- CLLS N/A
- NEN 71.00
- EPS
- CLLS N/A
- NEN 3.40
- Revenue
- CLLS $19,635,000.00
- NEN $79,924,036.00
- Revenue This Year
- CLLS $271.02
- NEN N/A
- Revenue Next Year
- CLLS $33.48
- NEN N/A
- P/E Ratio
- CLLS N/A
- NEN $23.80
- Revenue Growth
- CLLS N/A
- NEN 12.08
- 52 Week Low
- CLLS $0.96
- NEN $64.00
- 52 Week High
- CLLS $3.77
- NEN $84.00
- Technical
- Relative Strength Index (RSI)
- CLLS 37.13
- NEN 53.33
- Support Level
- CLLS $1.88
- NEN $79.00
- Resistance Level
- CLLS $2.08
- NEN $81.00
- Average True Range (ATR)
- CLLS 0.12
- NEN 0.57
- MACD
- CLLS -0.04
- NEN -0.48
- Stochastic Oscillator
- CLLS 17.31
- NEN 40.00
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership
New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating and selling real estate. The Partnership owns and operates various residential apartments, condominium units and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.